Concepedia

Maxim Grymonprez

MG

10

Publications

315

Citations

10

H-Index

2018

Active since

Affiliations

Ghent University Hospital(Current)

Ghent University

Erasmus MC

Vrije Universiteit Brussel

Universitair Ziekenhuis Brussel

Maxim Grymonprez is an author at Ghent University Hospital specializing in pharmacotherapy, thrombosis, and public health.

ORCID

Top concepts

Publications per year

2018–2023

10

Publications

10

Chronic obstructive pulmonary disease and the development of atrial fibrillation

Maxim Grymonprez, Vincent Vakaet, Maryam Kavousi et al. · International Journal of Cardiology · 2018 · 77 citations · Full text

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Maxim Grymonprez, Mirko Petrović, Tine L. De Backer et al. · Thrombosis and Haemostasis · 2023 · 56 citations · Full text

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

Maxim Grymonprez, Laura Carnoy, Andreas Capiau et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2023 · 41 citations · Full text

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

Maxim Grymonprez, Tine L. De Backer, Xander Bertels et al. · Frontiers in Pharmacology · 2023 · 33 citations · Full text

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study

Maxim Grymonprez, Andreas Capiau, Stéphane Steurbaut et al. · Frontiers in Cardiovascular Medicine · 2022 · 31 citations · Full text

Rows per page

1–5 of 10